Binder profile
CHEMBL2206162
Bioactivity hit from ChEMBL on a similar protein.
Bound to: PA1498 — pyruvate kinase
Identifiers
Database identifiers and provenance.
- Ligand ID
CHEMBL2206162- UniProt (similar protein)
Q6GG09- pchembl
- 6.650
- Target protein
- PA1498
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- MW ≤ 500 Da 390.3
- LogP ≤ 5 3.92
- H-bond donors ≤ 5 2
- H-bond acceptors ≤ 10 5
- Rotatable bonds ≤ 10 3
- TPSA ≤ 140 Ų 74.6
No PAINS structural alerts detected.
Chemical representations
Canonical representations for cheminformatics workflows.
CC(=NNC(=O)c1cc(Br)ccc1O)c1nc2ccccc2s1CC(=NNC(=O)c1cc(Br)ccc1O)c1nc2ccccc2s1
InChI=1S/C16H12BrN3O2S/c1-9(16-18-12-4-2-3-5-14(12)23-16)19-20-15(22)11-8-10(17)6-7-13(11)21/h2-8,21H,1H3,(H,20,22)InChI=1S/C16H12BrN3O2S/c1-9(16-18-12-4-2-3-5-14(12)23-16)19-20-15(22)11-8-10(17)6-7-13(11)21/h2-8,21H,1H3,(H,20,22)
XAZXOBJILDAGEL-UHFFFAOYSA-NXAZXOBJILDAGEL-UHFFFAOYSA-N
Provenance
Annotation context from LigQ_2, the internal TPW step that collects PDB, ChEMBL, and ZINC ligand evidence.
- Method
- LigQ nearest_k
- Source
- ChEMBL
- Curation
- pdb_similarity_tanimoto
- Binding sites
- PF02887
External resources
Open this ligand in third-party databases and cheminformatics tools.
- ChEMBL ChEMBL compound CHEMBL2206162 →
- UniProt UniProt Q6GG09 (homolog) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “CHEMBL2206162”) →
Other binders for this protein
Quick navigation to other ligands bound to PA1498.
PDB 10
Ligands co-crystallized with this protein (structural evidence).
ChEMBL 68
Compounds with measured inhibitory activity on this target (higher pchembl = more potent).
ZINC 50
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).